These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 6103811
1. Highly specific opiate receptors for dynorphin-(1-13) in the mouse vas deferens. Wüster M, Schulz R, Herz A. Eur J Pharmacol; 1980 Mar 21; 62(2-3):235-6. PubMed ID: 6103811 [No Abstract] [Full Text] [Related]
6. The direction of opiodid agonists towards mu-, delta- and epsilon-receptors in the vas deferens of the mouse and the rat. Wüster M, Schulz R, Herz A. Life Sci; 1980 Jul 14; 27(2):163-70. PubMed ID: 6249997 [No Abstract] [Full Text] [Related]
7. The in vitro pharmacology of D-Met2,Pro5-enkephalinamide. Rónai AZ, Berzétei IP, Bajusz S, Székely JI. J Pharm Pharmacol; 1981 Aug 14; 33(8):534-5. PubMed ID: 6115930 [No Abstract] [Full Text] [Related]
8. Differential effects of potassium on the potency of different opioids in the mouse vas deferens. Wüster M, Schulz R. Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug 14; 315(2):181-4. PubMed ID: 7207646 [Abstract] [Full Text] [Related]
9. Activation of K-opiate sites by dynorphin in the myenteric plexus. Yoshimura K, Huidobro-Toro JP, Lee NM, Loh HH, Way EL. Adv Biochem Psychopharmacol; 1982 Aug 14; 33():91-8. PubMed ID: 6127009 [No Abstract] [Full Text] [Related]
10. Lack of cross-tolerance between morphine and Leu-enkephalin in the mouse vas deferens. Illes P, Zieglgänsberger W, Herz A. Brain Res; 1980 Sep 15; 197(1):260-3. PubMed ID: 6249458 [No Abstract] [Full Text] [Related]
11. Lack of cross-tolerance on multiple opiate receptors in the mouse vas deferens. Schulz R, Wüster M, Krenss H, Herz A. Mol Pharmacol; 1980 Nov 15; 18(3):395-401. PubMed ID: 6258048 [No Abstract] [Full Text] [Related]
12. Dynorphin interaction at the kappa-opiate site. Huidobro-Toro JP, Yoshimura K, Lee NM, Loh HH, Way EL. Eur J Pharmacol; 1981 Jun 19; 72(2-3):265-6. PubMed ID: 6113976 [No Abstract] [Full Text] [Related]
14. Demonstration of the crucial role of the phenylalanine moiety in enkephalin analogues for differential recognition of the mu- and delta-receptors. Roques BP, Gacel G, Fournie-Zaluski MC, Senault B, Lecomte JM. Eur J Pharmacol; 1979 Nov 23; 60(1):109-10. PubMed ID: 230063 [No Abstract] [Full Text] [Related]
16. Opiate tolerance and cross-tolerance in the mouse vas deferens [proceedings]. Marshall I, Nasmyth PA, Phillips DG. Br J Pharmacol; 1979 May 23; 66(1):131P-132P. PubMed ID: 454927 [No Abstract] [Full Text] [Related]
17. Correlation between circular dichroism data and biological activities of 2,5 substituted enkephalin analogues. Soós J, Berzétei I, Bajusz S, Rónai AZ. Life Sci; 1980 Jul 14; 27(2):129-33. PubMed ID: 6249995 [No Abstract] [Full Text] [Related]
18. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens. Huidobro-Toro JP, Caturay EM, Ling N, Lee NM, Loh HH, Way EL. J Pharmacol Exp Ther; 1982 Jul 14; 222(1):262-9. PubMed ID: 6123591 [Abstract] [Full Text] [Related]
19. [Comparative studies of 2 methods for the quantitative measurement of endorphins in the cerebrospinal fluid. The mouse vas deferens and opiate-receptor binding]. Laorden ML, Olaso MJ, Miralles F, Puig MM. Arch Farmacol Toxicol; 1983 Aug 14; 9(2):165-70. PubMed ID: 6318675 [No Abstract] [Full Text] [Related]
20. The choice of opiate receptor subtype by neo-endorphins. Oka T, Negishi K, Kajiwara M, Watanabe Y, Ishizuka Y, Matsumiya T. Eur J Pharmacol; 1982 Apr 23; 79(3-4):301-5. PubMed ID: 6284522 [Abstract] [Full Text] [Related] Page: [Next] [New Search]